Search
for
Sort by
Research 30 of 1000+
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous adverse effects of targeted therapies
- Targeted immunotherapy for hair regrowth and regeneration
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Cancer-Related Alopecia: From Etiologies to Global Management
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Editorial: Targeted immunological therapies in dermatology
- Frontiers in alopecia areata pathobiology research
- The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket Immunosuppressives
- Alopecia and Hair Damage Induced by Oncological Therapy
- Exosome-Mediated Immunomodulation in Hair Regeneration: From Bench to Bedside
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Molecular mechanisms of viral oncogenesis in humans
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?